Q192R polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a biracial community: The Bogalusa Heart Study

Atherosclerosis

Volumn 177, Issue 1, 2004, Pages 167-174

  Srinivasan, Sathanur R ^a   Li, Shengxu ^a   Chen, Wei ^a   Tang, Rong ^b   Bond, M Gene ^b   Boerwinkle, Eric ^c   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Black white; Carotid intima media thickness; Lipoproteins; Paraoxanase Q192R polymorphism; Young adults

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARAOXANASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ARYLDIALKYLPHOSPHATASE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 5444220054     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.06.013     Document Type: Article

References (56)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoprotein that increases its atherogenicity N Engl J Med 320 1989 915 924
2. M. Navab, J.A. Berliner, and A.W. Watson The yin and yang of oxidation in the development of fatty streak: a review based in the 1996 George Lyman Duff Memorial Lecture Arterioscler Thromb Vasc Biol 16 1996 831 842
3. L.J. Fielding, and P.E. Fielding Molecular physiology of reverse cholesterol transport J Lipid Res 36 1995 211 228
4. M.I. Mackness, S. Arrol, C.A. Abbott, and P.N. Durrington Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxanase Atherosclerosis 104 1993 129 135
5. A.D. Watson, J.A. Berliner, and S.Y. Hama Protective effect of high-density lipoprotein associated paraoxanase: inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
6. M. Aviram, M. Rosenblat, and C.L. Bisgaier Paraoxanase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxanase J Clin Invest 101 1998 1581 1590
7. M.C. Blatter, R.W. James, S. Messmer, F. Barja, and D. Pometta Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein K-45: identity of K-45 with paraoxanase Eur J Biochem 211 1993 871 879
8. G.J. Kelso, W.D. Stuart, and R.J. Richter Apolipoprotein J is associated with paraoxanase in human plasma Biochemistry 33 1994 832 839
9. J. McElveen, M.I. Mackness, and C.M. Colley Distribution of paraoxan hydrolytic activity in serum of patients after myocardial infarction Clin Chem 32 1986 671 673
10. M.I. Mackness, D. Harty, and D. Bhatnagar Serum paraoxanase activity in familial hypercholesterolemia and insulin dependent diabetes mellitus Atherosclerosis 86 1991 193 199
11. R. Humbert, D.A. Adler, and C.M. Distche The molecular basis of the human serum paraoxanase activity polymorphism Nature Genet 3 1993 73 76
12. S. Adkins, K.N. Gan, M. Mody, and B.N. La Du Molecular basis for the polymorphic forms of human serum paraoxanase/arylerterase: glutamine or arginine at position 191, for the respective A or B allozymes Am J Hum Genet 52 1993 598 608
13. J. Ruiz, H. Blanche, and R.W. James Gln-Arg 192 polymorphism of paraoxanase and coronary heart disease in type 2 diabetes Lancet 346 1995 869 872
14. S. Serrato, and A.J. Marian A variant of human paraoxanase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease J Clin Invest 96 1995 3005 3008
15. D.K. Sanghera, N. Saha, C.E. Aston, and M.I. Kamboh Genetic polymorphism of paraoxanase and the risk of coronary heart disease Arterioscler Thromb Vasc Biol 17 1997 1067 1073
16. M.S. Antikainen, M. Murtomäki, and R. Syvänne The Gln-Arg 191 polymorphism of the human paraoxanase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns J Clin Invest 98 1996 883 885
17. S.M. Herrmann, H. Blanc, and O. Poirier The Gln/Arg polymorphism of human paraoxanase (PON 192) is not related to myocardial infarction in the ECTIM study Atherosclerosis 126 1996 299 303
18. Q. Chen, S.E. Reis, and M. Kammerer Association between the severity of angiographic coronary artery disease and paraoxanase gene polymorphism in the National Heart, Lung, and Blood Institute sponsored Women's Ischemic Syndrome Evaluation (WISE) study Am J Hum Genet 72 2003 13 22
19. N. Saha, A.C. Roy, S.H. Teo, J.S.H. Tay, and S.S. Ratnam Influence of serum paraoxanase polymorphism on serum lipids and apolipoproteins Clin Genet 40 1991 277
20. R.A. Hegele, J.H. Brunt, and P.W. Connelly A polymorphism of the paraoxanase gene associated with variation in plasma lipoproteins in a genetic isolate Arterioscler Thromb Vasc Biol 15 1995 89
21. B. Mackness, M.I. Mackness, and S. Arrol Serum peraoxanase (PON 1) 55 and 192 polymorphisms and paraoxanase activity and concentrations in non-insulin dependent diabetes mellitus Atherosclerosis 139 1998 341 349
22. J.P. Strong, G.T. Malcom, and C.A. McMahan Prevalence and extent of atherosclerosis in adolescents and young adultsImplications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study JAMA 281 1999 727 735
23. G.S. Berenson, S.R. Srinivasan, and W. Bao Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults The Bogalusa Heart Study N Engl J Med 338 1998 1650 1656
24. D.H. O'Leary, J.F. Polak, and R.A. Kronmal Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults N Engl J Med 340 1999 14 22
25. L.E. Chambless, G. Heiss, and A.R. Folsom Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study 146 1997 483 494
26. H.W. Hodis, W.J. Mack, and L. LaBree The role of carotid arterial intima-media thickness in predicting clinical coronary events Ann Intern Med 128 1998 262 269
27. J.L. Wofford, F.R. Kahl, and G.R. Howard Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis Arterioscler Thromb 11 1991 1787 1794
28. P.H. Davis, J.D. Davison, W.A. Riley, and R.M. Lauer Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study Circulation 104 2001 2815 2819
29. E.M. Urbina, S.R. Srinivasan, and R. Tang Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa Heart Study) Am J Cardiol 90 2002 953 958
30. A. Gnasso, C. Motti, and C. Irace The Arg allele in position 192 of PON 1 is associated with carotid atherosclerosis in subjects with elevated HDLs Atherosclerosis 164 2002 289 295
31. Y.M. Hu, H.M. Tian, and R. Lin Gln-Arg 192 polymorphism of paraoxanase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese Diab Res Clin Pract 61 2003 21 27
32. H.B. Cao, A. Girard-Globa, and S. Serusclat Lack of association between carotid intima-media thickness and paraoxanase gene polymorphism in non-insulin-dependent diabetes mellitus Atherosclerosis 138 1998 361 366
33. F.R. Leus, M.E. Wittekock, J. Prins, J.J.P. Kastelein, and H.A.M. Voorbij Paraoxanase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia Atherosclerosis 149 2000 371 377
34. T. Sakai, B. Matsuura, and M. Onji Serum paraoxanase activity and genotype distribution in Japanese patients with diabetes mellitus Intern Med 37 1998 581 584
35. Am J Med Sci Suppl. 1 1995 S1 S138
36. M.G. Bond, R. Barnes, and W.A. Riley High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC) J Neuroimaging 1 1991 68 73
37. R. Tang, M. Henning, and B. Thomasson Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis (ELSA) J Hypertens 18 2000 197 201
38. S.R. Srinivasan, and G.S. Berenson Serum lipoproteins in children and methods for study LA. Lewis Handbook of Electrophoresis 1983 CRC Boca Raton, FL 185 204
39. D.N. Nevin, A. Zambon, and C.E. Furlong Paraoxanase genotypes, lipoprotein lipase activity, and HDL Arterioscler Thromb Vasc Biol 16 1996 1243 1249
40. B. Mackness, M.I. Mackness, and P.N. Durrington Paraoxanase activity in two healthy populations with differing rates of coronary heart disease Eur J Clin Invest 30 2000 4 10
41. D.M. Shih, L. Gu, and S. Hama Genetic-dietary regulation of serum paraoxanase expression and its role in atherogenesis in mouse model J Clin Invest 97 1996 1630 1639
42. S. Sen-Banerjee, X. Siles, and H. Campos Tobacco smoking modifies association between Gln-Arg 192 polymorphism of human paraoxanase gene and risk of myocardial infarction Arterioscler Thromb Vasc Biol 20 2000 2120 2126
43. P.N. Durrington, B. Mackness, and M.I. Mackness Paraoxanase and atherosclerosis Arterioscler Thromb Vasc Biol 221 2001 473 480
44. M. Aviram, S. Billecke, and R. Sorensen Paraoxanase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxanase activities Selective action of human paraoxanase allozymes Q and R Arterioscler Thromb Vasc Biol 18 1998 1617 1624
45. H. Cao, A. Girard-Globa, F. Berthezene, and P. Moulin Paraoxanase protection of LDL against peroxidation is independent of its extensive activity towards parzoxan and is unaffected by the Q → R genetic polymorphism J Lipid Res 40 1999 133 139
46. K. Kuremoto, Y. Watanabe, and H. Ohmura R/R genotype of human paraoxanase (PON 1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects J Atheroscler Thromb 10 2003 85 92
47. M. Senti, M. Tomas, J. Marrugat, R. Elosua for the REGICOR Investigators Paraoxanase 1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs Arterioscler Thromb Vasc Biol 21 2001 415 420
48. M.N. Sack, D.J. Roder, and R.O. Cannon III Oestrogen and inhibition of oxidation of low-density lipoproteins in post-menopausal women Lancet 343 1994 269 270
49. J.F. Arral, S. Clamens, and C. Pechet Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production Proc Natl Acad Sci U S A 93 1996 4108 4113
50. M. Senti, C. Aubo, and M. Tomas Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxanase gene Metabolism 49 2000 557 559
51. Y. Liu, J. Zhang, and R.R. Watson Environmental tobacco smoke promotes heart disease Cardiovasc Rev Report 21 2000 589 594
52. E. Nishio, and Y. Watanabe Cigarette smoke extract inhibits plasma paraoxanase activity by modification of the enzyme's free thiols Biochem Biophys Res Commun 236 1997 289 293
53. J.E. Hokanson, and M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 1996 213 219
54. J.R. McNamara, J.L. Jenner, Z. Li, P.W.F. Wilson, and E.J. Schaefer Change in LDL particle size is associated with change in plasma triglyceride concentration Arterioscler Thromb 12 1992 1284 1290
55. A. Chait, R. Brazg, D. Tribble, and R. Krauss Susceptibility of small, dense low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B Am J Med 94 1993 350 356
56. B. Mackness, G.K. Davies, and W. Turkie Paraoxanase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21 2001 1451 1457